Venture capital investors may not be hitting the pause button entirely, but they certainly scaled back on mega-rounds this past week, with just a couple of startup financings breaking past the multiple-hundred-million-dollar mark. While the overall landscape reflected a more measured pace of deployment, capital continued to flow into high-conviction sectors, led heavily by artificial intelligence infrastructure, specialized biotech, robotics-driven construction, and innovative healthcare platforms.
The most substantial check of the period went to AI infrastructure provider Modal Labs, which commanded a massive $750 million round, followed closely by construction automation unicorn Icon, which secured $200 million. Beyond these two frontrunners, the past week’s top ten rounds demonstrated robust investor interest spanning a diverse array of industries, including RNA therapies, climate-risk property insurance, advanced semiconductor systems, and AI-driven clinical documentation.
Topping the charts this week is Modal Labs, a New York-headquartered provider of robust cloud infrastructure tailored for AI inference and various demanding computational applications. The company successfully closed a massive $750 million Series D funding round led by prominent venture capital firm Accel. This massive injection of capital values the business at an impressive $15.75 billion. Highlighting the explosive demand for its specialized cloud infrastructure, Modal Labs revealed that it recently surpassed an annual revenue run rate of $1 billion, positioning it firmly among the heavyweight champions of the enterprise AI ecosystem.
Securing the second-largest spot on the weekly roundup is Icon, a prominent Austin, Texas-based developer of robotic construction systems widely recognized for its pioneering 3D-printed homes. Icon closed on a $200 million Series D funding round, which was co-led by institutional giants Baillie Gifford and BlackRock. The construction technology unicorn is navigating a period of hyper-growth, reporting that it is currently on a trajectory to achieve a fourfold increase in revenue over the course of the year.
Biotechnology and genetic medicine also captured a significant share of investor wallets this week, claiming multiple spots among the top ten transactions. Coming in at number three is Soufflé Therapeutics, a Boston-based developer specializing in advanced RNA therapies. The company raised $135 million in a Series B financing round led by Juvia Group, acting alongside a broad and active syndicate of institutional biotech investors.
Shortly behind in the biotech sector is Estuary Biotherapeutics, a Menlo Park, California-based startup focusing on the development of novel genetic medicines for patients suffering from serious and degenerative kidney diseases. The company officially launched with a total of $103 million in financing. This initial financial foundation consists of $93 million secured in a Series A round led by RA Capital Management, supplemented by $10 million in previously undisclosed seed capital.
Artificial intelligence applications tailored for enterprise operations and developer tooling continued to attract significant capital. Labelbox, an eight-year-old San Francisco-based developer of technology designed to train and evaluate AI models while deploying agents that improve dynamically through experience, picked up $100 million in Series E funding. The financing round for Labelbox was led by Infinitum Partners.
Healthcare technology and AI-driven clinical workflows represented another major area of deployment for venture capital firms. Redwood City, California-based Suki, a specialized provider of AI tools designed to seamlessly convert clinical conversations into structured intelligence for medical documentation, billing codes, and other administrative healthcare workflows, announced a $90 million Series E financing. The round drew participation from prominent backers including Healthier Capital and Crosslink Capital.
Addressing the critical and growing need for accessible home healthcare support, Abby Care closed on $82 million in Series C funding. The five-year-old San Francisco-based startup operates a specialized platform designed to help family members become certified, paid caregivers capable of delivering professional-grade care directly in the home. The financing was led by Transformation Capital, bringing crucial resources to the burgeoning care-economy sector.
Climate risk and the ongoing property insurance crisis also commanded venture attention. Stand, a three-year-old San Francisco-based startup providing specialized insurance solutions for residential homes located in areas facing higher risks of natural disasters and climate-related damage, secured $70 million in a Series C funding round. The investment valued the young company at $1 billion, earning it unicorn status, with Saga Ventures Management leading the transaction.
Rounding out the list of the week’s largest transactions are hardware and efficiency-focused infrastructure plays. Mueon Corp., a Portland, Oregon-based semiconductor systems company building an advanced modular platform designed specifically for AI workloads and hyperscale computing, completed a $65 million Series A funding round led by Maverick Silicon. Meanwhile, New York-based North.cloud, a provider of an infrastructure spend intelligence and automation platform aimed at reining in ballooning cloud costs, raised $60 million in a Series B round led by PeakSpan Capital.
This week’s data reflects a market where investors remain highly selective, prioritizing proven enterprise traction, massive revenue scaling, and critical technological infrastructure over speculative bets, while still displaying a clear willingness to back market leaders with substantial capital when the fundamentals align.
